August 02, 2011; 77 (5) Editorials
Weekend high-dosage prednisone
A new option for treatment of Duchenne muscular dystrophy
Richard T. Moxley, Shree Pandya
First published July 13, 2011, DOI: https://doi.org/10.1212/WNL.0b013e318227b272
Weekend high-dosage prednisone
A new option for treatment of Duchenne muscular dystrophy
Richard T. Moxley, Shree Pandya
Neurology Aug 2011, 77 (5) 416-417; DOI: 10.1212/WNL.0b013e318227b272
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 77 no. 5 416-417
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published July 13, 2011.
Article Versions
- Previous version (July 13, 2011 - 12:49).
- You are viewing the most recent version of this article.
Copyright & Usage:
Copyright © 2011 by AAN Enterprises, Inc.
Author Disclosures
- Richard T. Moxley III, MD and
- Shree Pandya, PT, DPT, MS
- Richard T. Moxley III, MD and
- Shree Pandya, PT, DPT, MS
- Address correspondence and reprint requests to Dr. Richard T. Moxley III, Department of Neurology, Box 673, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642 Richardt_moxley{at}urmc.rochester.edu
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Special Article
Practice Parameter: Corticosteroid treatment of Duchenne dystrophyReport of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology SocietyR. T. Moxley III, S. Ashwal, S. Pandya et al.Neurology, January 10, 2005 -
Articles
Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophyD.M. Escolar, L.P. Hache, P.R. Clemens et al.Neurology, July 13, 2011 -
Special Article
Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophyReport of the Guideline Development Subcommittee of the American Academy of NeurologyDavid Gloss, Richard T. Moxley III, Stephen Ashwal et al.Neurology, February 01, 2016 -
Article
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle functionEric P. Hoffman, Benjamin D. Schwartz, Laurel J. Mengle-Gaw et al.Neurology, August 26, 2019